Social Technologies Drive Competitive Advantage in Pharmaceuticals
Partner with us to improve performance across the pharmaceutical value chain
With pharmaceutical companies facing enormous cost and productivity pressures, they are increasingly looking for innovative ways to drive meaningful performance improvements. Their complex and distributed nature makes them ideally suited for social business capabilities.
Unisys’ Unified Social Business provides social capabilities targeted to your most critical business needs. From the development of social listening capabilities to dramatically improve the productivity and impact of your medical science liaisons (MSLs), to improving collaboration and knowledge sharing across research teams, social technologies drive game changing capabilities across the value chain.
The reward is clear: Pharmaceutical companies that harness enterprise social business capabilities will be best positioned to succeed.